This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Integra LifeSciences Reports Fourth Quarter 2012 Financial Results

Items included in GAAP net income and location where each item is recorded are as follows:

(In thousands)
Three Months Ended December 31, 2012
 
Item   Total Amount COGS(a) SG&A(b) Amort.(c) Interest Exp(Inc)(d) Tax(e)
Plainsboro, New Jersey manufacturing facility remediation costs $746 $746 $— $— $— $—
Global ERP implementation charges 4,287 4,287
Facility optimization charges 2,617 838 1,779
Certain employee termination charges 217 156 61
Discontinued product lines charges 310 310
Acquisition-related charges 485 485
Convertible debt non-cash interest 236 236
Intangible asset amortization expense 6,132 1,582 4,550
Estimated income tax impact from adjustments and other items (5,850) (5,850)
Depreciation expense 7,357          
Stock-based compensation expense 2,420          
             
a)  COGS - Cost of goods sold
b)  SG&A - Selling, general and administrative
c)  Amort. - Intangible asset amortization
d)  Interest Inc (Exp) - Interest income (expense), net
e)  Tax - Income tax expense
 
Three Months Ended December 31, 2011
(In thousands)
 
Item   Total Amount COGS (a) R&D (b) SG&A (c) Amort. (d) Interest Exp/(Inc) (e) Tax (f)
Global ERP implementation charges $5,236 $— $— $5,236 $— $— $—
Certain employee termination and related charges 1,859 369 1,490
Facility optimization charges 829 829
Discontinued product lines charges 262 262
Acquisition-related charges 1,026 1,373 (347)
Plainsboro, New Jersey manufacturing facility remediation costs 4,082 4,082
Certain executive compensation charges 4,912 4,912
Convertible debt non-cash interest 3,472 3,472
Intangible asset amortization expense 7,003 2,179 4,824
Estimated income tax impact from adjustments and other items (12,643) (12,643)
Depreciation expense 5,866
Stock-based compensation expense 2,996
 
a)  COGS - Cost of goods sold
b)  R&D - Research and development
c)  SG&A - Selling, general and administrative
d)  Amort. - Intangible asset amortization
e)  Interest Inc(Exp) - Interest income (expense), net
f)  Tax - Income tax expense

Items included in GAAP net income and location where each item is recorded are as follows:

7 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,757.91 +138.40 0.79%
S&P 500 2,077.42 +14.31 0.69%
NASDAQ 5,013.1230 +26.2560 0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs